Publications by authors named "A da Palma Guerreiro"

Easily accessible through tabletop experiments, paraxial fluids of light are emerging as promising platforms for the simulation and exploration of quantumlike phenomena. In particular, the analogy builds on a formal equivalence between the governing model for a Bose-Einstein condensate under the mean-field approximation and the model of laser propagation inside nonlinear optical media under the paraxial approximation. Yet, the fact that the role of time is played by the propagation distance in the analog system imposes strong bounds on the range of accessible phenomena due to the limited length of the nonlinear medium.

View Article and Find Full Text PDF

Glycopeptides derived from the glycoprotein mucin-1 (MUC1) have shown potential as tumor-associated antigens for cancer vaccine development. However, their low immunogenicity and non-selective conjugation to carriers present significant challenges for the clinical efficacy of MUC1-based vaccines. Here, we introduce a novel vaccine candidate based on a structure-guided design of an artificial antigen derived from MUC1 glycopeptide.

View Article and Find Full Text PDF

Correction for 'An impedimetric sensor based on molecularly imprinted nanoparticles for the determination of trypsin in artificial matrices - towards point-of-care diagnostics' by Sabrina Di Masi , 2024, , 742-750, https://doi.org/10.1039/D3AY01762A.

View Article and Find Full Text PDF

Diclofenac (DCF) and ibuprofen (IBU) are pharmaceutical compounds frequently detected in aquatic compartments worldwide. Several hazard effects including developmental abnormalities and redox balance impairment have been elucidated in aquatic species, but multiple endocrine evaluations are scarce. Therefore, the present study aimed to assess the disruptive physiological effects and toxicity of DCF and IBU isolated and combined, using females of the native freshwater teleost Astyanax lacustris.

View Article and Find Full Text PDF

Mucin-1 (MUC1) glycopeptides are exceptional candidates for potential cancer vaccines. However, their autoantigenic nature often results in a weak immune response. To overcome this drawback, we carefully engineered synthetic antigens with precise chemical modifications.

View Article and Find Full Text PDF